Jürgen Raths
Corporate Officer/Principal bij Executive Insight AG
Profiel
Jürgen Raths currently works at Executive Insight AG, as Associate Partner from 2015.
Dr. Raths also formerly worked at Arpida AG, as President & Chief Executive Officer in 2009, Advanz Pharma Switzerland SARL, as President & Chief Executive Officer from 2010 to 2013, Vesselon, Inc., as Director, PAION AG, as Chief Operating Officer from 2015 to 2017, and Eli Lilly (Suisse) SA, as Head-Critical Care Europe from 1990 to 2008.
Dr. Raths received his doctorate degree from the University of Bonn.
Actieve functies van Jürgen Raths
| Bedrijven | Functie | Begin |
|---|---|---|
| Executive Insight AG | Corporate Officer/Principal | 01-01-2015 |
Eerdere bekende functies van Jürgen Raths
| Bedrijven | Functie | Einde |
|---|---|---|
| PAION AG | Operationeel Directeur | 01-03-2017 |
Advanz Pharma Switzerland SARL
 Advanz Pharma Switzerland SARL Pharmaceuticals: MajorHealth Technology Advanz Pharma Switzerland SARL manufactures and wholesales pharmaceuticals. The company is headquartered in Geneva, Switzerland. | Algemeen Directeur | 01-01-2013 |
Arpida AG
 Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | President | 14-12-2009 |
| Eli Lilly (Suisse) SA | Corporate Officer/Principal | 01-01-2008 |
Vesselon, Inc.
 Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Directeur/Bestuurslid | - |
Opleiding van Jürgen Raths
| University of Bonn | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PAION AG | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Arpida AG
Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Health Technology |
Advanz Pharma Switzerland SARL
Advanz Pharma Switzerland SARL Pharmaceuticals: MajorHealth Technology Advanz Pharma Switzerland SARL manufactures and wholesales pharmaceuticals. The company is headquartered in Geneva, Switzerland. | Health Technology |
| Eli Lilly (Suisse) SA | |
| Executive Insight AG | |
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Health Technology |
